İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

SAEED SHOAIE

DOÇENT (Kısmi Zamanlı, Yurt Dışı)

BİRUNİ ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Biyoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 33
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 31 Q2 1 Q3 1 Q4 0
WoS (JCR) Q1 28 Q2 4 Q3 0 Q4 1
TR Index 0 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 3
Üst %10 makale 18
Ort. yüzdelik 86.2%
Üst %1 payı 9.1%
Üst %10 payı 54.5%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 33 yayın

Scopus (SJR)
Q1 31 Q2 1 Q3 1 Q4 0
WoS (JCR)
Q1 28 Q2 4 Q3 0 Q4 1
TR Index
0 makale

Makale listesi

  1. 2026 Fungal infection drives metabolic reprogramming in epithelial cells via aerobic glycolysis and an alternative TCA cycle shunt Science Advances DOI 10.1126/sciadv.aea0405 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.5%
  2. 2026 Temporal dynamics of gut biosynthetic gene clusters link persistent colonization and engraftment in fecal microbiota transplantation Gut Microbes DOI 10.1080/19490976.2026.2634469 YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.9%
  3. 2025 Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance Journal of Hepatology DOI 10.1016/j.jhep.2024.09.046 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.0%
  4. 2025 Microbiome signatures of virulence in the oral-gut-brain axis influence Parkinson’s disease and cognitive decline pathophysiology Gut Microbes DOI 10.1080/19490976.2025.2506843 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.3%
  5. 2025 Microbial collagenase activity is linked to oral–gut translocation in advanced chronic liver disease Nature Microbiology DOI 10.1038/s41564-025-02223-0 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.7%
  6. 2025 L-proline supplementation affects non-volatile flavour perception through oral microbiome metabolic pathways npj Science of Food DOI 10.1038/s41538-025-00643-0 YÖKSİS SJR Q1 JCR Q1 OpenAlex 79.4%
  7. 2025 Nitrate supplementation affects taste by changing the oral metabolome and microbiome npj Biofilms and Microbiomes DOI 10.1038/s41522-025-00689-8 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.0%
  8. 2025 Extensively acquired antimicrobial-resistant bacteria restructure the individual microbial community in post-antibiotic conditions npj Biofilms and Microbiomes DOI 10.1038/s41522-025-00705-x YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.3%
  9. 2024 Microbiological and molecular profile of furcation defects in a population with untreated periodontitis Journal of Clinical Periodontology DOI 10.1111/jcpe.14034 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.5%
  10. 2024 Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based Approach Biomedicines DOI 10.3390/biomedicines12102237 YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.2%
  11. 2024 Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial Brain Communications DOI 10.1093/braincomms/fcae478 YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.0%
  12. 2024 Transient colonizing microbes promote gut dysbiosis and functional impairment npj Biofilms and Microbiomes DOI 10.1038/s41522-024-00561-1 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 96.5%
  13. 2024 Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases Biomedicines DOI 10.3390/biomedicines12040927 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.5%
  14. 2024 Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis Alimentary Pharmacology & Therapeutics DOI 10.1111/apt.17899 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.5%
  15. 2024 Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis Gut DOI 10.1136/gutjnl-2023-330699 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 96.8%
  16. 2024 Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach International Journal of Molecular Sciences DOI 10.3390/ijms25147868 YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.0%
  17. 2024 Detection and consistency of mucosal fluid T lymphocyte phenotypes and their relationship with blood, age and gender Journal of Immunological Methods DOI 10.1016/j.jim.2024.113731 YÖKSİS SJR Q3 JCR Q4 OpenAlex 64.3%
  18. 2023 Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients Journal of Translational Medicine DOI 10.1186/s12967-023-04192-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.5%
  19. 2023 Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase Nutrients DOI 10.3390/nu15030577 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 90.1%
  20. 2023 Systematic diet composition swap in a mouse genome-scale metabolic model reveals determinants of obesogenic diet metabolism in liver cancer iScience DOI 10.1016/j.isci.2023.106040 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.9%

Akademisyenlere dön